Janney Montgomery Scott
ARMP icon

Janney Montgomery Scott’s Armata Pharmaceuticals ARMP Stock Holding History

Janney Montgomery Scott’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-115
Closed -$64K – 677
2016
Q1 		$64K Hold
115
– – ﹤0.01% 1235
2015
Q4 		$64K Hold
115
– – ﹤0.01% 1331
2015
Q3 		$64K Buy
+115
New +$105K ﹤0.01% 1355

Other funds holding ARMP

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return

Janney Montgomery Scott's ARMP Position: Q2 2016 in Review

Janney Montgomery Scott sold out of Armata Pharmaceuticals (ARMP) in Q2 2016, closing a stake of 115 shares — an estimated $64K sold.

Janney Montgomery Scott first reported a position in ARMP in Q3 2015 and held it in 3 quarters. The position peaked at $64K in Q1 2016. 17 funds tracked by Wall St. Rank hold ARMP as of Q2 2016.

  • Janney Montgomery Scott reported no remaining Armata Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Janney Montgomery Scott sold 115 Armata Pharmaceuticals shares in Q2 2016, an estimated $64K.
  • Janney Montgomery Scott first reported a position in Armata Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Janney Montgomery Scott's Armata Pharmaceuticals position peaked at $64K in Q1 2016.
  • 17 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2016.

Based on Janney Montgomery Scott's 13F filing for Q2 2016, filed 5 Aug 2016.